Hotline:
+ 49 (0) 2204 2918806

Market studies for category X

Items 1 to 10 of 527 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 53
  1. Net price*
    Year
  2. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Crohn's Disease - Pipeline Review, H2 2013

    Global Markets Direct
    310 pages
    Global Markets Direct’s, 'Crohn's Disease - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Crohn's Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key playe
    Englisch | Zukunftsanalyse | SKU: 355138
  3. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Helicobacter Pylori Infections - Pipeline Review, H2 2013

    Global Markets Direct
    61 pages
    Global Markets Direct’s, 'Helicobacter Pylori Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Helicobacter Pylori Infections, complete with latest updates, and special features on late-stage and discontinued proje
    Englisch | Zukunftsanalyse | SKU: 354850
  4. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Bladder Cancer - Pipeline Review, H2 2013

    Global Markets Direct
    184 pages
    Global Markets Direct’s, 'Bladder Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Bladder Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players
    Englisch | Zukunftsanalyse | SKU: 355202
  5. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Shionogi & Co., Ltd. - Product Pipeline Review - 2013

    Global Markets Direct
    78 pages
    Global Markets Direct’s pharmaceuticals report, “Shionogi & Co., Ltd. - Product Pipeline Review - 2013” provides data on the Shionogi & Co., Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This
    Englisch | Zukunftsanalyse | SKU: 354914
  6. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Agenus, Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    33 pages
    Global Markets Direct’s pharmaceuticals report, “Agenus, Inc. - Product Pipeline Review - 2013” provides data on the Agenus, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built
    Englisch | Zukunftsanalyse | SKU: 354978
  7. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Trius Therapeutics, Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    29 pages
    Global Markets Direct’s pharmaceuticals report, “Trius Therapeutics, Inc. - Product Pipeline Review - 2013” provides data on the Trius Therapeutics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projec
    Englisch | Zukunftsanalyse | SKU: 355042
  8. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Alvine Pharmaceuticals, Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    24 pages
    Global Market Direct’s pharmaceuticals report, “Alvine Pharmaceuticals, Inc. - Product Pipeline Review - 2013” provides data on the Alvine Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant
    Englisch | Zukunftsanalyse | SKU: 354754
  9. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Atherosclerosis - Pipeline Review, H2 2013

    Global Markets Direct
    251 pages
    Global Markets Direct’s, 'Atherosclerosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Atherosclerosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key playe
    Englisch | Zukunftsanalyse | SKU: 355106
  10. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Drug Addiction - Pipeline Review, H2 2013

    Global Markets Direct
    79 pages
    Global Markets Direct’s, 'Drug Addiction - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Drug Addiction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players
    Englisch | Zukunftsanalyse | SKU: 354818
  11. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2013

    Global Markets Direct
    292 pages
    Global Markets Direct’s, 'Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Amyotrophic Lateral Sclerosis, complete with latest updates, and special features on late-stage and discontinued project
    Englisch | Zukunftsanalyse | SKU: 355170

Items 1 to 10 of 527 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 53